Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PFE
PFE logo

PFE News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

PFE News

Dividend Investment Opportunities in Pfizer and Bristol Myers Squibb

2h agoFool

Pfizer's Dividend Risks Heighten Amid Challenges

9h agoFool

High Dividend Stock Analysis: Verizon Leads

1d agoFool

Pfizer Eyes Kailera Acquisition to Expand Weight Loss Portfolio

5d agoFool

Alnylam Pharmaceuticals Shares Drop 24%, Yet Optimism Persists

5d agoFool

Alnylam Pharmaceuticals Reports Strong Q1 Performance

5d agoNASDAQ.COM

Two Stocks Wall Street Loves and One to Sell

5d agoYahoo Finance

Comparing Dividends: Pfizer vs. Verizon

6d agoFool

PFE Events

07/07 13:00
Pfizer Shares Up 1.33% with Active Options Trading
Moderately bullish activity in Pfizer (PFE), with shares up 32c, or 1.33%, near $24.04. Options volume running well above average with 112k contracts traded and calls leading puts for a put/call ratio of 0.6, compared to a typical level near 0.57. Implied volatility (IV30) is higher by 1.4 points near 24.93,and above the 52wk median, suggesting an expected daily move of $0.38. Put-call skew steepened, indicating increased demand for downside protection, following a downgrade to Hold at HSBC.
07/02 12:30
Pfizer Shares Rise 1.7% to $24.29
Moderately bullish activity in Pfizer (PFE), with shares up 40c, or 1.7%, near $24.29. Options volume roughly in line with average with 64k contracts traded and calls leading puts for a put/call ratio of 0.23, compared to a typical level near 0.57. Implied volatility (IV30) is higher by 0.5 points near 20.21,in the bottom quartile of the past year, suggesting an expected daily move of $0.31. Put-call skew steepened, indicating increased demand for downside protection.

PFE Monitor News

Pfizer Dismissed from Antitrust Lawsuit, Reducing Legal Exposure

Jun 24 2026

Pfizer CFO Resigns Amid Market Concerns

Jun 18 2026

Pfizer Reports Strong Q1 Earnings and Strategic Acquisition

May 08 2026

NHS Expands Eligibility for Pfizer's RSV Vaccine

Apr 02 2026

Pfizer's Atirmociclib Study Achieves Key Milestone

Mar 17 2026

Pfizer's HYMPAVZI Receives FDA Priority Review for Hemophilia Treatment

Feb 06 2026

Pfizer's Obesity Drug PF'3944 Shows Promising Trial Results

Feb 04 2026

Pfizer Reports Strong Q4 Earnings Amid Covid Sales Decline

Feb 03 2026

PFE Earnings Analysis

Pfizer Earnings: Strategic Shifts Amid COVID Revenue Drop- Intellectia AI™
8 months ago
Comprehensive Company Earnings Report for Investors- Intellectia AI™
11 months ago
Pfizer Earnings: Growth Strategies and Future Outlook- Intellectia AI™
11 months ago
Pfizer Displays Robust Growth Amidst Challenges - Intellectia AI™
1 years ago
Pfizer Reports Strong ThirdQuarter 2024 Financial Results and Increases FullYear Guidance
1 years ago

People Also Watch